chlapec jed Derbevilleův test kras marker Zůstává kus dopad
The current understanding on the impact of KRAS on colorectal cancer - ScienceDirect
A): Dynamic change in tumor marker (CA125) (blue line) and KRAS G12V... | Download Scientific Diagram
Computational Analysis of KRAS Mutations: Implications for Different Effects on the KRAS p.G12D and p.G13D Mutations | PLOS ONE
Frontiers | Targeting KRAS in Lung Cancer Beyond KRAS G12C Inhibitors: The Immune Regulatory Role of KRAS and Novel Therapeutic Strategies
Frontiers | Targeting KRAS: The Elephant in the Room of Epithelial Cancers
Integrated multi-omics characterization of KRAS mutant colorectal cancer
Hitting an Elusive Target in Pancreatic Cancer - NCI
KRAS-mutant non-small cell lung cancer: Converging small molecules and immune checkpoint inhibition - eBioMedicine
The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC) - ScienceDirect
KRAS Screening & Profiling
Cancers | Free Full-Text | Treatment Strategies for KRAS-Mutated Non-Small-Cell Lung Cancer
Combination of KRAS gene silencing and PI3K inhibition for ovarian cancer treatment - ScienceDirect
The Trouble With KRAS - Cancer Commons
KRAS mutations predict response to EGFR inhibitors - ScienceDirect
Targeting KRAS mutant cancers: from druggable therapy to drug resistance | Molecular Cancer | Full Text
Chemically modified MIR143-3p exhibited anti-cancer effects by impairing the KRAS network in colorectal cancer cells: Molecular Therapy - Nucleic Acids
KRAS mutation A treatment target
Cancers | Free Full-Text | KRAS in NSCLC: State of the Art and Future Perspectives
Frontiers | Targeting KRAS Mutant in Non-Small Cell Lung Cancer: Novel Insights Into Therapeutic Strategies
Cells | Free Full-Text | KRAS-Mutant Lung Cancer: Targeting Molecular and Immunologic Pathways, Therapeutic Advantages and Restrictions
Immune modulatory effects of oncogenic KRAS in cancer | Nature Communications
An integrative pharmacogenomics analysis identifies therapeutic targets in KRAS-mutant lung cancer - eBioMedicine
Differential Reprogramming of Isogenic Colorectal Cancer Cells by Distinct Activating KRAS Mutations | Journal of Proteome Research
IJMS | Free Full-Text | KRAS-Mutant Non-Small-Cell Lung Cancer: From Past Efforts to Future Challenges
KRAS Mutation in Colon Cancer: A Marker of Resistance to EGFR-I Therapy | SpringerLink